These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35122926)

  • 1. Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models.
    He HJ; Xiong X; Zhou S; Zhang XR; Zhao X; Chen L; Xie CL
    Neurochem Int; 2022 May; 155():105297. PubMed ID: 35122926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease.
    Lv H; Liu J; Wang L; Zhang H; Yu S; Li Z; Jiang F; Niu Y; Yuan J; Cui X; Wang W
    Cell Biochem Biophys; 2014 Nov; 70(2):1433-8. PubMed ID: 24989681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effect of Curcumin Against Cerebral Ischemia-Reperfusion Via Mediating Autophagy and Inflammation.
    Huang L; Chen C; Zhang X; Li X; Chen Z; Yang C; Liang X; Zhu G; Xu Z
    J Mol Neurosci; 2018 Jan; 64(1):129-139. PubMed ID: 29243061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
    Ge H; Yan Z; Zhu H; Zhao H
    Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.
    Burgaz S; García C; Gómez-Cañas M; Navarrete C; García-Martín A; Rolland A; Del Río C; Casarejos MJ; Muñoz E; Gonzalo-Consuegra C; Muñoz E; Fernández-Ruiz J
    Mol Cell Neurosci; 2021 Jan; 110():103583. PubMed ID: 33338634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy.
    Sokouti H; Mohajeri D; Nourazar MA
    Physiol Res; 2022 Aug; 71(4):551-560. PubMed ID: 36165412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.
    Du XX; Xu HM; Jiang H; Song N; Wang J; Xie JX
    Neurosci Bull; 2012 Jun; 28(3):253-8. PubMed ID: 22622825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
    Turan D; Abdik H; Sahin F; Avşar Abdik E
    Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
    Zou J; Chen Z; Wei X; Chen Z; Fu Y; Yang X; Chen D; Wang R; Jenner P; Lu JH; Li M; Zhang Z; Tang B; Jin K; Wang Q
    Cell Death Dis; 2017 Jun; 8(6):e2854. PubMed ID: 28569795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
    Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
    Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses.
    Xu YQ; Long L; Yan JQ; Wei L; Pan MQ; Gao HM; Zhou P; Liu M; Zhu CS; Tang BS; Wang Q
    CNS Neurosci Ther; 2013 Mar; 19(3):170-7. PubMed ID: 23279934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
    Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
    Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease.
    Jia Y; Mo SJ; Feng QQ; Zhan ML; OuYang LS; Chen JC; Ma YX; Wu JJ; Lei WL
    J Mol Neurosci; 2014 May; 53(1):117-24. PubMed ID: 24390959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson's disease models.
    Zhuang XX; Wang SF; Tan Y; Song JX; Zhu Z; Wang ZY; Wu MY; Cai CZ; Huang ZJ; Tan JQ; Su HX; Li M; Lu JH
    Cell Death Dis; 2020 Feb; 11(2):128. PubMed ID: 32071296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of Limonin (LM) exerts neuroprotective effects by inhibiting neuron autophagy and microglial activation in 6-OHDA-injected rats.
    Gao X; He D; Liu Y; Cui M; Li Z; Li J; He Y; Wang H; Ye B; Fu S; Liu D
    Int Immunopharmacol; 2023 Oct; 123():110739. PubMed ID: 37536186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
    Cui Q; Li X; Zhu H
    Mol Med Rep; 2016 Feb; 13(2):1381-8. PubMed ID: 26648392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
    Gu XS; Wang F; Zhang CY; Mao CJ; Yang J; Yang YP; Liu S; Hu LF; Liu CF
    Neurochem Res; 2016 Nov; 41(11):2923-2936. PubMed ID: 27447883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK/mTOR mediated autophagic inhibition.
    Zhang J; Cai Q; Jiang M; Liu Y; Gu H; Guo J; Sun H; Fang J; Jin L
    Exp Gerontol; 2017 Mar; 89():45-56. PubMed ID: 28099881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.
    Song S; Nie Q; Li Z; Du G
    Pathol Res Pract; 2016 Apr; 212(4):247-51. PubMed ID: 26922613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.